The target lesion is in a prosthetic vascular bypass graft or within 1 cm of a graft anastomosis;
The target lesion is in an aneurysm or associated with an aneurysm in the vessel segment either proximal or distal to the target lesion.
The lesion requires treatment other than percutaneous transluminal angioplasty (PTA) prior to stent placement;
Other lesions requiring treatment or surgery within 30 days of the procedure (pre or post) with the exception of the non-target lesion(s).
Inadequate distal run-off.
History of bleeding diatheses or coagulopathy or will refuse blood transfusions;
Creatinine \> 2.5 mg/dl
Platelet count \<80,000 cells/mm3 or \>700,000 cells/mm3, or a white blood cell (WBC) of \<3,000 cells/mm3
Participation in another investigational device or drug study and has not completed the primary endpoint(s) or that clinically interferes with the study endpoints;
